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Abstract
Background: Transplant recipients are chronically ill patients, who require lifelong follow-up to manage co-
morbidities and prevent graft loss. This necessitates a system of care that is congruent with the Chronic Care
Model. The eleven-item self-report Patient Assessment of Chronic Illness Care (PACIC) scale assesses whether
chronic care is congruent with the Chronic Care Model, yet its validity for heart transplant patients has not been
tested.
Methods: We tested the validity of the English version of the PACIC, and compared the similarity of the internal
structure of the PACIC across English-speaking countries (USA, Canada, Australia and United Kingdom) and across
six languages (French, German, Dutch, Spanish, Italian and Portuguese). This was done using data from the cross-
sectional international BRIGHT study that included 1378 heart transplant patients from eleven countries across 4
continents. To test the validity of the instrument, confirmatory factor analyses to check the expected
unidimensional internal structure, and relations to other variables, were performed.
Results: Main analyses confirmed the validity of the English PACIC version for heart transplant patients. Exploratory
analyses across English-speaking countries and languages also confirmed the single factorial dimension, except in
Italian and Spanish.
Conclusion: This scale could help healthcare providers monitor level of chronic illness management and improve
transplantation care.
Trial registration: Clinicaltrials.gov ID: NCT01608477, first patient enrolled in March 2012, registered retrospectively:
May 30, 2012.
Keywords: PACIC short form, Heart transplantation, Chronic care model, Language, Multi-center trial, Transplant
team
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Background
Transplantation needs to be regarded as a chronic con-
dition as patients remain dependent on life-long medical
follow-up after transplantation and have to follow a
complex therapeutic regimen. Moreover, new co-
morbidities develop after transplantation, often due to
the side effects of immunosuppressive drugs [1]. World-
wide, transplant recipients are thus part of a growing
group of patients living with chronic diseases and multi-
morbidity, representing a major burden for communities
and healthcare systems in terms of morbidity, disability,
mortality and healthcare costs.
Improving care for chronically ill patients implies a sys-
tem of care that integrates building blocks of the Chronic
Care Model [2, 3], i.e. support for self-management, deliv-
ery system design (e.g. continuity of care), decision sup-
port, clinical information systems, community resources
and policies, as well as organization of healthcare. In fact,
for more than a decade, the implementation of initiatives
targeting better coordination and integration of care for
patients with chronic disease based on the Chronic Care
Model, has flourished [3–5]. Attention to care models in
transplantation, based on principles of chronic illness
management, has also increased [1, 6], and first evidence
shows that reengineering transplant follow-up based on
the principles of chronic illness management results in
better adherence, clinical outcomes, better quality of life,
and less health resource utilization [7, 8].
The Patient Assessment of Chronic Illness Care (PACIC)
scale [9] assesses how chronic illness care, from the patient’s
perspective, is congruent with the Chronic Care Model [2,
3]. It was developed by Glasgow et al. [9], and to our know-
ledge, has almost exclusively been used and validated in pa-
tient populations with highly prevalent chronic diseases such
as diabetes [10–16], chronic pulmonary obstructive diseases
[13], arthritis [17] and heart failure [16, 18]. Whereas these
prevalent chronic diseases represent those with the highest
societal burden in terms of morbidity, disability, mortality
and cost [19–22], the level of chronic illness care in trans-
plantation remains to be explored. In fact, transplant recipi-
ents represent a unique group of patients. They not only live
with a chronic condition, as patients are not cured with a
transplant, and often present with multiple co-morbidities
requiring complex treatments and frequent follow-ups, but
are also cared for in tertiary care facilities and always by mul-
tiple different healthcare professionals.
The PACIC could be used for assessing the level of
chronic illness care in transplantation and provide insights
in specific aspects of transplant management that could
be improved. Moreover, the PACIC could also be used to
benchmark transplant centers in relation to their level of
chronic illness management, and this information can be
taken into consideration when assessing variability in clin-
ical outcomes among centers.
In this context, the primary goal of our study was to
test the validity of the existing English version of the
PACIC scale in a new group of patients, namely heart
transplant recipients. The secondary – exploratory –
goal of our study was to compare, in this population of
chronic patients, the similarity of the internal structure
of the PACIC across English-speaking countries and
across various languages.
Methods
Study design
We performed secondary data-analyses, based on cross-
sectional data from the BRIGHT study (Building Re-
search Initiative Group: Chronic Illness Management
and Adherence in Transplantation) [23], a multi-center,
multi-continental study in heart transplantation aiming
at describing chronic illness management practice pat-
terns among centers, countries, and continents in heart
transplantation. Detailed information on the BRIGHT
study aims and methods can be found elsewhere [23].
Using a multi-stage sampling approach, a convenience
sample of countries (i.e. Australia, Belgium, Brazil,
Canada, France, Germany, Italy, Spain, Switzerland, the
UK and the USA) and heart transplant centers (36 centers
and minimally 2 per country) were included. Depending
on the number of clinicians eligible, a random sample of a
maximum of 5 clinicians per center were recruited in this
study, and a random sample of 1677 among the 2523 eli-
gible adult (> 18y) single-organ heart transplant recipients
(1–5 years post-transplantation) were approached for par-
ticipating (proportional sampling based on heart trans-
plantation center volume). Details on inclusion/exclusion
criteria and sample size calculation can be found in the
BRIGHT methods paper [23].
Sample
Among the 1677 eligible participants, 244 declined and
36 died before completing the questionnaire, leaving
1397 participants. Out of the 1397 heart transplant re-
cipients included in the BRIGHT study, 19 were ex-
cluded from our study population as they had not
answered any of the PACIC questions/items. Among the
1378 patients who answered at least one PACIC ques-
tion, 43% answered in English, 16% in Spanish, 13% in
French, and less than 10% answered in Italian, in
German, in Portuguese and in Dutch, respectively (for de-
tails see Fig. 1). Patients came from 36 centers which 11%
are from non-urban areas (one Dutch-speaking center and
three English-speaking centers) and 17% are from non-
university teaching hospitals (three Portuguese-speaking
centers and three English-speaking centers). There were
17 English-speaking centers, 5 Spanish-speaking centers, 6
French-speaking centers, four German-speaking centers,
three Portuguese-speaking centers, three Italian-speaking
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centers and one Dutch-speaking center. There was one
center with patients answering questionnaires in French,
in German or in Italian (Switzerland), and another an-
swering in English or in French (Canada).
The English population of patients (overall and by
countries), which represents the main population of
interest of the study, is described in Table 1. The mean
age was 54.3 years, 70% of English speaking patients
were men, and 52% of the causes underlying heart dis-
eases were for idiopathic cardiomyopathy, 34% for ische-
mic cardiomyopathy, 4% congenital and 1% for valvular
disease. Characteristics of the other language popula-
tions are presented in Appendix 1.
Measures
The BRIGHT study used different sources of informa-
tion (i.e. patient, clinician, heart transplant program dir-
ector, medical file) to assess variables of interest, i.e. [1]
the BRIGHT patient interview questionnaire, [4] the
BRIGHT patient self-report (written) questionnaire, [1]
the BRIGHT clinician questionnaire, [6] the BRIGHT
transplant director questionnaire, and [7] the BRIGHT
medical chart structured data collection form [23]. Fol-
lowing Wild et al. recommendations [24], patient ques-
tionnaires were translated from the original English
version to Dutch, French, German, Italian, Spanish and
Brazilian Portuguese by professional translators in a cul-
turally sensitive way, and then pilot tested (further de-
tails are available elsewhere [23]). For this study, we will
focus on the BRIGHT patient self-reported data.
To describe our sample, data included patients’ socio-
demographics and health information: age (in year), gen-
der (being male yes/no), ethnicity (Caucasian yes/no),
education attainment (primary school, secondary school
and college/university), employment status (being (self-
)employed (part-time/full time paid work) yes/no),
Charlson comorbidity index post heart transplantation
[25] (19 items with weighted score, total ranging from 0
to 37), causes of underlying heart disease (congenital, is-
chemic, idiopathic, valvular, other) and number of year
since transplantation.
To assess the level of chronic illness care from the pa-
tient’s perspective, we used the Patient Assessment of
Chronic Illness Care (PACIC). More specifically we used
the short version of the PACIC, an eleven-items self-
reported measure [11, 18, 26, 27]. Patients were asked to
score their care experience over the past 6 months in
view of the eleven-items (for entire scale see footnote of
Table 2) on a 5-point Likert scale: 1) none of the time,
2) a little of the time, 3) some of the time, 4) most of the
time and 5) always.
Finally, we also used questions relating to the trans-
plant team: if the transplant team advised the patient to
exercise during the past year (yes/no), if the transplant
team discussed about the intake of immunosuppressive
drugs in daily life (yes/no), the level of satisfaction with
transplant team (mean of twelve questions going from
1 = very dissatisfied to 5 = very satisfied [28]) and the
trust in the transplant team (mean of ten questions, go-
ing from 1 = strongly disagree’ (low trust) to ‘5= strongly
agree’ (high trust) [29]).
Validation process
Following the American Psychological Association
guidelines of standards for educational and psychological
testing, the validation process for an existing scale is
composed by two steps: validation of the internal struc-
ture of the scale and the relation to other variables [30].
Actually, since we were not developing a new scale but
working with the English version of an existing one, we
Fig. 1 Distribution of the sample by language and by countries (within English-speaking countries)
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did not repeat the content and response process steps
(necessary to consider when validating a new scale)
which had been conducted initially in English by Glas-
gow and his colleagues [9].
Statistical analyses
First, we conducted descriptive analyses to characterize
patients (percentage for ordinal or categorical data;
means and standard deviation (SD) for continuous data)
according to the language of the questionnaires they
filled in, and, for English-speaking patients, according to
their country. We also described the distribution of the
PACIC eleven-items (mean, standard deviation, median,
distribution by response category, and percentage of
missing values) for each of these groups.
Second, we followed the first step of the American
Psychological Association recommended validation
process: validation of the internal structure of the
scale. Therefore, we ran confirmatory factor analyses
based on a polychoric correlation (correlation estima-
tion between theorized normally distributed continu-
ous latent variables measured through ordinal
variables) matrix (weighted least squares estimation
method (WLSMV) [31] to test the single dimension
factorial structure of the PACIC [11, 18, 26, 27], and
its expected internal structure. This type of confirma-
tory factor analyses was chosen because of the ordinal
structure of the data (PACIC items measured on a 5-
point Likert scale) [32]. Pairwise deletion technique
(available-case analysis) was used with WLSMV to
handle missing data.
Third, to explore the extent to which the internal
structure was equivalent across English-speaking
countries (USA, Canada, Australia and United King-
dom) and languages (French, German, Dutch, Span-
ish, Italian and Portuguese), we tested three forms of
measurement invariance (i.e. measurement equiva-
lence [33]): configural, metric and scalar invariance.
This was done by comparing a series of multigroup
confirmatory factor analyses gradually increasing
model constraints. Whereas configural invariance re-
quires the same factorial structure across groups,
metric invariance requires equivalent loading across
groups and scalar invariance requires equivalent
thresholds across groups (for further details see [34–
36]). In other words, configural invariance implies the
same factorial structure across groups, metric variance
implies that the loadings (the “weights” of each item)
are similar across groups (i.e. the latent construct is
understood similarly across groups) and scalar invari-
ance allows conducting valid mean comparisons
across groups. Goodness of fits of the various con-
firmatory factor analyses models were then tested
using the Root Mean Square Error of Approximation
(RMSEA) and Weighted Root Mean Square Residual
(WRMR, recommended for ordinal data [37]); the lat-
ter two were checked jointly because of the sensitivity
to misspecified factor loading for the RMSEA [38].
The Tucker Lewis index (TLI) and the Comparative
Fit Index (CFI) were also presented since they are less
affected by sample size [38, 39]. Models were consid-
ered to present a “good fit” if the RMSEA was < 0.05,
Table 2 Distribution of the PACIC eleven-items: all English-speaking patients (N = 596)
Response categories, %
Item Mean (SD) Median Never Generally not Some-times Most of the time Always Missing
values1 2 3 4 5
1 3.2 1.5 3 18.3 19.5 17.5 15.8 28.2 0.8
2 4.8 0.6 5 1.5 0.3 1.5 12.4 84.1 0.2
3 3.4 1.4 4 12.1 18.3 19.5 18.6 31.2 0.3
4 3.7 1.6 5 16.1 12.6 6.7 8.7 54.7 1.2
5 2.6 1.5 2 31.0 24.0 14.3 8.4 21.3 1.0
6 3.8 1.4 4 10.1 9.4 17.0 19.6 44.0 0.0
7 3.4 1.5 4 17.8 15.8 12.6 17.1 36.2 0.5
8 3.4 1.5 4 18.3 14.8 12.4 16.3 36.7 1.5
9 3.6 1.4 4 12.3 11.6 18.8 18.1 38.4 0.8
10 3.3 1.5 3 16.8 16.6 18.6 11.7 35.4 0.8
11 3.2 1.5 3 19.1 16.1 18.3 17.3 28.4 0.8
SD Standard deviation.
Items: 1) Given choices about treatment to think about; 2) Satisfied that my care was well organized. 3) Helped to set specific goals to improve my eating or
exercise; 4) Given a copy of my treatment plan; 5) Encouraged to go to a specific group or class to help me cope with my heart transplantation; 6) Asked
questions, either directly or with a questionnaire, about my health habits; 7) Helped to make a treatment plan that I could carry out in my daily life; 8) Helped to
plan ahead so I could take care of my transplanted heart even in hard times; 9) Asked how my heart transplantation affects my life; 10) Contacted after a visit to
see how things were going; 11) Told how my visits with other types of doctors, like an eye doctor or surgeon, helped my treatment [9].
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[40], WRMR < 1.00 [37], TLI > 0.97 and CFI > 0.97
[41]. Models were considered to present an “accept-
able fit” if RMSEA’s were between 0.05 and 0.08 and
TLI’s and CFI’s between 0.95 and 0.97. For compar-
ability reasons, we also computed ordinal alphas (i.e.
ordinal reliability coefficients), instead of the usual
Cronbach’s alpha because the latter takes into ac-
count the ordinal nature of the variables [42].
Finally, we conducted the second step of the stan-
dards for educational and psychological testing: the
relation to other variables [30]. After having identified
variables that we a priori hypothesized to be related
to PACIC scores (i.e. variables related to the trans-
plant team), we used them to explore associations be-
tween PACIC scores and the following variables: the
transplant team’s advice for exercise during the past
year (yes/no), discussion regarding intake of immuno-
suppressive with the transplant team, patient levels of
satisfaction and levels of trust with the transplant
team. Our hypotheses were that: a) patients who were
advised to exercise will have higher PACIC scores
than those who were not; b) patients who discussed
intake of immunosuppressive medication with the
transplant teams will have higher total PACIC scores
than those who had not; c) high patients’ satisfaction
with the transplant team will be correlated with high
PACIC scores; and d) high levels of trust with the
transplant team will be correlated with high PACIC
scores. According to the different distributions of the
latter variables, Spearman correlations were used to
test the association between PACIC and continuous
variables, whereas t-tests were used for independent
groups in dummy variables. Analyses were conducted
for the English version, English-speaking countries
and different language groups. Whereas Stata 12 was
used for most statistical analyses, Mplus 7 [31] was
used to run confirmatory factor analyses and R [43]
was used to run ordinal alphas.
Results
Level of chronic illness care from patient’s perspective
(PACIC scores)
Table 2 provides the distribution of the PACIC eleven-
items for all English-speaking patients. Whereas 96% of
patients completed all items of the questionnaire and
the percentage of missing values by item was very low
(variation between 0 and 1.5%), a high percentage of pa-
tients ticked the highest response category (variation be-
tween 21 and 84%) with 8 out of eleven-items presenting
ceiling effects (> 30% of the patients). On the other hand,
the lowest response category was less often selected
(variation between 1.5 and 19.1%), except for item 5
(31.0%), which can be considered as a floor effect.
Details of the distribution of the PACIC items are shown
in Appendixes 2a, 2b, 3a and 3b (across English-
speaking countries and across language groups).
PACIC structure
The results of confirmatory factor analyses based on a
polychoric correlation matrix are presented in Tables 3
and 4, by countries for English-speaking patients, and by
language groups for the other patients, respectively. Ac-
ceptable to good fits of the single factor structure
(RMSEA < 0.08, WRMR <.1.00, CFI > 0.97, TLI > 0.97)
were found for the English version of the PACIC and in
all English-speaking countries except for one index for
USA (RMSEA 0.092 instead of 0.080) and for Australia
(RMSEA 0.087 instead of 0.080). Acceptable to good fits
were found for the French and German versions. How-
ever, the Dutch version showed acceptable to good fits
except for the RMSEA (0.110 instead of 0.080), and the
Portuguese and the Italian versions showed at least two
fits slightly away from the defined acceptable fits thresh-
old. The Spanish version did not reach the expected
thresholds.
Loadings were similar both across English-speaking
countries and between the English, French and German
versions. The Dutch and the Portuguese versions did not
differ too much for the latter and appeared to be sub-
stantially different for the Spanish and the Italian ver-
sions, particularly for items 1 and 2.
Configural invariance was established across English-
speaking countries, meaning that the factorial structure
was identical (i.e. a single dimension) across English-
speaking countries. This was not the case for the other
language groups. Indeed, whereas the Spanish version
did not show acceptable fits, the Spanish and the Italian
patients did not use the whole scale of answering, i.e.
some anchors (response modality) for item 2 and 4 were
never chosen, which prevented us from testing multi-
group invariance. Despite these results, we found config-
ural invariance between the English, French, German,
Dutch and Portuguese versions with acceptable fits
(RMSEA =0.073, CFI =0.986, TLI =0.982). Metric invari-
ance was found neither across English-speaking coun-
tries nor across language groups.
Relationship between PACIC’s score and variables of the
field
For the English version, the hypothesized relationships
between PACIC scores and the variables related to
transplant team were confirmed (Table 5). In fact, we
found that: a) patients advised to exercise reported
higher PACIC scores than those who were not; b) pa-
tients with whom immunosuppressive medication intake
had been discussed reported higher PACIC scores than
those with whom it had not; c) higher levels of satisfac-
tion with the transplant team were associated with
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Table 4 Loadings and model fits (confirmatory factor analyses based on polychoric correlation matrix) by language groups
Item English (n = 596) French (n = 189) German (n = 106) Dutch (n = 51) Spanish (n = 223) Italian (n = 114) Portuguese (n = 99)
1 0.65 0.61 0.63 0.70 0.30 0.25 0.49
2 0.39 0.47 0.44 0.58 0.73 0.31 0.47
3 0.82 0.79 0.74 0.89 0.77 0.71 0.68
4 0.76 0.69 0.57 0.81 0.80 0.64 0.59
5 0.78 0.68 0.70 0.77 0.97 0.63 0.74
6 0.74 0.74 0.76 0.40 0.97 0.56 0.74
7 0.9 0.87 0.84 0.90 0.76 0.65 0.84
8 0.91 0.95 0.87 0.90 0.81 0.84 0.83
9 0.79 0.81 0.74 0.70 0.75 0.71 0.67
10 0.78 0.76 0.69 0.62 0.76 0.48 0.69
11 0.78 0.58 0.71 0.77 0.80 0.68 0.60
RMSEA 0.079 0.074 0.070 0.110 0.169 0.075 0.087
CFI 0.985 0.984 0.982 0.971 0.970 0.948 0.947
TLI 0.981 0.980 0.977 0.964 0.962 0.934 0.933
WRMR 0.985 0.719 0.625 0.664 1.879 0.778 0.719
Alpha ordinal 0.930 0.920 0.900 0.890 0.900 0.810 0.880
RMSEA Root Mean Square Error of Approximation, CFI Comparative Fit Index, TLI The Tucker Lewis index, WRMR Weighted Root Mean Square Residual. Good
Goodness of fit (GoF): RMSEA < 0.05, CFI > 0.97; TLI > 0.97; WRMR < 1.00; And acceptable GoF: RMSEA < 0.08, CFI > 0.95, TLI > 0.95.
Table 3 Loadings and model fits (confirmatory factor analyses based on polychoric correlation matrix) for the PACIC English version,
overall and by countries
Country
Item Whole English-speaking sample (n = 596) USA (n = 337) Canada (n = 110) UK (n = 98) Australia (n = 51)
1 0.65 0.63 0.57 0.82 0.61
2 0.39 0.45 0.49 0.29 0.34
3 0.82 0.80 0.81 0.84 0.81
4 0.76 0.66 0.74 0.78 0.78
5 0.78 0.77 0.72 0.81 0.87
6 0.74 0.64 0.74 0.79 0.90
7 0.90 0.85 0.89 0.88 0.96
8 0.91 0.87 0.89 0.95 0.96
9 0.79 0.77 0.84 0.76 0.94
10 0.78 0.69 0.74 0.83 0.83
11 0.78 0.76 0.72 0.77 0.70
RMSEA 0.079 0.092 0.075 0.022 0.087
CFI 0.985 0.969 0.984 0.999 0.993
TLI 0.981 0.962 0.980 0.999 0.991
WRMR 0.985 0.987 0.600 0.478 0.531
Alpha ordinal 0.930 0.920 0.920 0.930 0.920
RMSEA Root Mean Square Error of Approximation, CFI Comparative Fit Index, TLI The Tucker Lewis index, WRMR Weighted Root Mean Square Residual. Good
Goodness of fit (GoF): RMSEA < 0.05, CFI > 0.97; TLI > 0.97; WRMR < 0.100; And acceptable GoF: RMSEA < 0.08, CFI > 0.95, TLI > 0.95.
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higher PACIC scores; and d) higher levels of trust were
correlated with higher PACIC scores. Similar results
were found across English speaking countries (for de-
tails, see appendix 4), except for the UK, where no sig-
nificant differences were found between the PACIC
scores of patients who had received advice to exercise
and those who had not, and no significant relation was
identified between the PACIC scores and the levels of
trust in the transplant team.
Our hypotheses were also confirmed for the French,
German and Spanish versions, whereas they were only
partially confirmed for the Italian version of the ques-
tionnaire (no significant differences were found between
the PACIC scores of patients who received advice to ex-
ercise and those who did not), and were not confirmed
at all for the Dutch and Portuguese versions.
Discussion
This study aimed to test the validity of the existing Eng-
lish version of the PACIC scale for heart transplant re-
cipients, a new group of chronically ill patients not
considered in previous PACIC studies. As a result, the
examination of the internal structure of the scale showed
goodness of fit values within acceptable range for a sin-
gle dimension, and the analysis of the relationships with
the variables tested confirmed our hypotheses. In fact,
perceived level of chronic illness management (PACIC
scores) appeared to be positively associated with treat-
ment satisfaction and levels of trust in the transplant-
ation team, and higher perceived levels of chronic illness
management were identified when patients had been ad-
vised to exercise and when the immunosuppressive
treatment had been discussed. This study also intended
to explore the extent to which the internal structure of
the questionnaire was equivalent in different English-
speaking countries (USA, Canada, Australia and United
Kingdom) and across language groups (French, German,
Dutch, Spanish, Italian and Portuguese). We confirmed
the unique factorial dimension across English-speaking
countries as well as for the French, German, Dutch and
Portuguese versions of the questionnaire but not for the
Italian and the Spanish versions of the scale. In addition,
while hypothesized relationships between perceived level
of chronic illness management and other variables were
coherent across English-speaking countries and for the
French, German and Spanish versions of the question-
naire, respectively, they were not for the remaining lan-
guages (i.e. Dutch, Italian and Portuguese).
Confirming the structural dimension of a question-
naire (i.e. configural invariance, one dimension in the
case of the PACIC) is necessary but not sufficient to
compare scores across groups and languages. With con-
figural invariance the latent factor of the questionnaire is
composed by the same items but this does not mean
that they are included in the same proportion (metric in-
variance) or that the anchors (response modalities) are
identical across groups and between languages (scalar
invariance). Our analyses did not confirm metric invari-
ance criteria: even if the items composing the PACIC
score were the same, they were not combined similarly
across groups and languages. This suggests that patients
speaking different languages do not interpret/understand
the questionnaire similarly. In fact, to ensure a common
understanding of self-perceived integrated care, the
PACIC score – the latent factor of the PACIC scale -
should be composed of at least the same proportion of
each item across English speaking countries and across
languages (i.e. metric invariance). Varying meanings or
interpretations can arise from cultural or/and healthcare
system differences indeed. The latter two phenomena,
which cannot easily be disentangled, represent key ex-
planations of existing differences to consider when mak-
ing international comparisons. We nevertheless have to
remember that questionnaires (e.g. PACIC) are most
often developed for clinical purposes such as following
the evolution of a patient state (e.g. comparison of pa-
tients’ scores over time) or investigating the impact of
an intervention (e.g. comparison of patients’ scores be-
fore and after an intervention). This means that any
international comparisons should be made with great
caution, given that those results represent a detour of
the questionnaires’ initial use. Currently, further explora-
tions of the impact of cultural and healthcare system dif-
ferences on the assessment of provided care are needed.
As mentioned before, we found a positive association
between the PACIC score and satisfaction results.
Table 5 relations between PACIC global score and other variables by languages
English (n = 596) French (n = 189) German
(n = 106)
Dutch
(n = 51)
Spanish
(n = 223)
Italian
(n = 114)
Portuguese
(n = 99)
Advice to exercise (yes = 1, no = 0) (1) 1.0 *** 0.7 ** 0.7 ** 0.1 ns
Transplant team discussed intake
immunosuppressants (yes = 1, no = 0) (1)
1.1 *** 1.0 ***
Satisfaction with transplant team (2) 0.364 *** 0.216 ** 0.439 *** 0.271 . 0.375 *** 0.323 *** 0.058 ns
Trust in transplant team (2) 0.268 *** 0.293 *** 0.400 *** 0.128 ns 0.324 *** 0.211 * −0.012 ns
Statistical test: (1) t-test: mean differences, (2) spearman correlation; p-value: *** p < 0.001; ** p < 0.01; * p < 0.05; p < 0.10; ns non-significant p-value; N.B.: empty
cells when category “no” less than 10 persons.
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Among the twelve satisfaction items, two (‘how consist-
ent the information of the team was’ and ‘how under-
standable their information was’) are also part of the
Chronic Care Model measured with the PACIC. This
may contribute to the positive correlation between satis-
faction and the perceived level of chronic illness man-
agement. The other satisfaction items focus on how the
transplantation team takes care of patients by listening
and being present (and also, for example, by being
‘friendly’, ‘encouraging’ and ‘supportive’). These commu-
nication items probably allow the patient to ask ques-
tions and to obtain information on his/her disease. As
such, patients may be reassured and report better
chronic illness management. This is also supported by
the positive association found between trust in the trans-
plantation team and level of chronic illness management.
In fact, trust in the transplantation team and care satis-
faction should remain central when considering the inte-
gration of care of chronically ill patients.
This study presents two main strengths. Firstly, we tar-
geted a population of chronically ill patients which were
not previously involved in PACIC-related studies. Sec-
ondly, we used data from patients from a variety of
countries and languages, allowing us to obtain a more
comprehensive perspective on the validity of the PACIC
scale. Nevertheless, two limitations need to be addressed.
First, although the overall sample is large, the sample
size per language or country was low for Dutch, Portu-
guese, UK and Australia (less than 100) and German,
French, Italian and Canada (less than 200), which may
explain why acceptable fits were not always reached. In
fact, Muthén and Muthén [44] suggest a minimum of
300 patients when working with ordinal data; a number
that was only reached when pooling the English-
speaking countries or for the USA. A second limiting
factor lies in the fact that some language groups in-
cluded patients from countries with different cultures
and health care systems. Indeed, pooling countries
speaking and using the same language does not mean
that the same context/culture is shared. For example,
differences in healthcare systems or expectations as well
as care experiences may influence the way PACIC items
are understood by patients. These previous reasons
brought us to consider our secondary aim - similarity of
the internal structure of the PACIC across English-
speaking countries and across various languages - as
only exploratory.
Conclusion
Heart transplant patients represent an increasing group
of chronically ill patients requiring complex treatments
as well as life-long follow-up in a variety of care struc-
tures and with multiple healthcare professionals. Our re-
sults show that the English version of the PACIC, a scale
assessing how level of chronic illness care perceived by
patients is consistent with the recommendations of the
Chronic Care Model, is valid in an international sample
of heart transplant patients. Further validation efforts
are needed since this scale is also very likely to be rele-
vant for other solid organ transplant groups of patients
who are also chronically ill. In the field of transplant-
ation care, this tool could help healthcare professionals
and providers in monitoring chronic illness management
over time, adjusting it to patients’ needs and experiences,
and thus improving transplantation care as well as pro-
viding insights into specific aspects of transplant man-
agement that could be improved. While awaiting results
of further research comparing patients over time or
comparing groups of patients where only the type of
intervention varies, comparisons across countries or lan-
guages should be performed with caution since inter-
pretation of the questions by patients can differ
depending on the context, culture or healthcare system.
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